Loading...
Loading...
Among the 7 tracked institutional investors we monitor, PBYI (PUMA BIOTECHNOLOGY INC) is held with a combined value of $74.73M across 11,956,014 shares. The largest holder is BlackRock, Inc. with a position worth $23.00M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$74.73M
Total Shares Held
11,956,014
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $23.00M | 0.00% | -1.2% |
| 2 | VANGUARD GROUP INC | $22.60M | 0.00% | New |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $12.41M | 0.02% | -8.5% |
| 4 | MILLENNIUM MANAGEMENT LLC | $9.44M | 0.00% | +8793.2% |
| 5 | STATE STREET CORP | $5.86M | 0.00% | +4.6% |
| 6 | FMR LLC | $1.23M | 0.00% | +17.1% |
| 7 | CITADEL ADVISORS LLC | $191.44K | 0.00% | -83.1% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of PBYI with a position worth $23.00M, representing 0.00% of their portfolio. In total, 7 institutional investors hold PBYI with a combined value of $74.73M.
In the most recent quarter, 1 fund opened a new position in PBYI. Additionally, 3 increased their holdings and 3 reduced their positions.
Institutional investors hold $74.73M worth of PBYI stock across 7 positions. The largest institutional holder is BlackRock, Inc. with $23.00M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For PBYI, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their PBYI positions.